Financial insights of AMPH

MyFinsight

For the quarter ending 2025-09-30, AMPH made $191,840K in revenue. $17,350K in net income. Net profit margin of 9.04%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenues	191,840	174,414	170,528	180,251
Cost of revenues	93,194	87,924	85,277	89,613
Gross profit	98,646	86,490	85,251	90,638
Selling, distribution, and marketing	11,505	10,235	11,866	9,602
General and administrative	39,467	13,991	15,996	13,966
Research and development	22,354	20,080	20,096	17,612
Total operating expenses	73,326	44,306	47,958	41,181
Income from operations	25,320	42,184	37,293	49,457
Interest income	2,246	1,921	2,089	2,728
Interest expense	6,284	6,281	6,286	7,882
Other income (expenses), net	231	1,511	-2,234	3,057
Total non-operating income (expenses), net	-3,807	-2,849	-6,431	-2,097
Income before income taxes	21,513	39,335	30,862	47,360
Income tax provision	4,163	8,305	5,577	7,473
Income before equity in losses of unconsolidated affiliate	17,350	31,030	25,285	39,888
Equity in losses of unconsolidated affiliates	-	-	-	-143
Net income attributable to amphastar pharmaceuticals, inc	-	-	25,285	39,880
Net income	17,350	31,030	25,285	39,880

Earnings per share, basic	0.38	0.66	0.53	0.82
Earnings per share, diluted	0.37	0.64	0.51	0.76
Weighted average number of shares outstanding, basic	46,474,000	46,949,000	47,641,000	-64,000
Weighted average number of shares outstanding, diluted	47,677,000	48,128,000	49,890,000	65,333.333